The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospective, randomized, multicenter phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial).
 
Mathias J. Rummel
Honoraria - Roche
Research Funding - Roche
 
Wolfgang Knauf
Consulting or Advisory Role - Roche/Genentech
Expert Testimony - Roche
 
Martin Goerner
No Relationships to Disclose
 
Ulrike Soeling
No Relationships to Disclose
 
Elisabeth Lange
No Relationships to Disclose
 
Bernd Hertenstein
No Relationships to Disclose
 
Jochen Eggert
No Relationships to Disclose
 
Georg C Schliesser
Stock and Other Ownership Interests - Bayer; Roche
Travel, Accommodations, Expenses - Novartis
 
Rudolf Weide
Research Funding - Biotest; Celgene; Medac; Novartis
Travel, Accommodations, Expenses - Biotest; Celgene; Medac; Novartis
 
Klaus Blumenstengel
No Relationships to Disclose
 
Ninia Detlefsen
No Relationships to Disclose
 
Axel Hinke
No Relationships to Disclose
 
Frank Kauff
No Relationships to Disclose
 
Juergen Barth
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; CSL Behring; Medac; Mundipharma; Pfizer; Roche
Travel, Accommodations, Expenses - Mundipharma; Novartis; Roche; Takeda